Smoking Increases Side Effect, Recurrence Risk in Prostate Cancer
the ONA take:
The fact that smoking contributes to a poor prognosis in many diseases and conditions is well-known. A recent study from Memorial Sloan Kettering Cancer Center in New York City confirmed the effects on smoking on patients with prostate cancer.
Those who smoke have increased risks of experiencing treatment-related side effects and cancer recurrences, or even dying from the disease. These researchers studied 2,358 patients who underwent external beam radiotherapy for prostate cancer between 1988 and 2005, of which 2,156 had a history of smoking.
Risk of cancer relapse was 40% higher and risk of metastasis and cancer-related death was more than 2-times higher in patients who were current smokers compared with patients who were never smokers.
Current and former smokers also had a higher likelihood of experiencing side effects, such as urinary toxicity, related to radiotherapy. "Less optimal tumor control outcomes among smokers could possibly be explained by the influence of less oxygen concentration within the treated tumors among smokers, which is known to lead to less sensitivity of the cells being killed off by radiation treatments," the researchers noted.
Recent study confirmed the effects on smoking on patients with prostate cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|